Aptamer-based radiopharmaceuticals for diagnostic imaging and targeted radiotherapy of epithelial tumors

Brazilian Archives of Biology and Technology

Volumn 51, Issue SPECIALISSUE, 2008, Pages 77-82

  Missailidis, Sotiris ^a   Perkins, Alan ^b   Santos Filho, Sebastião David ^c   da Fonseca, Adenilson de Souza ^c,d   Bernardo Filho, Mario ^c,e  

^a OPEN UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^d Centro Universitário Serra dos Órgãos Centro de Ciências da Saúde   (Brazil)

^e INSTITUTO NACIONAL DE CÂNCER   (Brazil)

Author keywords

Aptamer; Diagnostic imaging; Epithelial tumor; Radiopharmaceutical; Radiotherapy

Indexed keywords

EID: 68249117318     PISSN: 15168913     EISSN: 16784324     Source Type: Journal    
DOI: 10.1590/S1516-89132008000700013     Document Type: Article

References (23)

1. Bacher, J. M.; Ellington, A. D. (1998), Nucleic acid selection as a tool for drug discovery, Drug Discov Today, 3, 265-273.
2. Belimezi, M., "Cancer Immunotherapy". In-Anticancer Therapeutics, Missailidis S (editor). Wiley and Sons Ltd, United Kingdom.
3. Berezovski, M.; Drabovich, A.; Krylova, S. M.; Musheev, M.; Okhonin, V.; Petrov, A.; Krylov, S. N. (2005), Nonequilibrium capillary electrophoresis of equilibrium mixtures: a universal tool for development of aptamers. J Am Chem Soc., 127, 3165-71.
4. Borbas, K. E.; Ferreira, C. S. M.; Perkins, A.; Bruce, J. I.; Missailidis, S. (2007), "Design and synthesis of mono- and multimeric targeted radiopharma-ceuticals based on novel cyclen ligands coupled to anti-MUC1 aptamers for the diagnostic imaging and targeted radiotherapy of cancer", J Bioconj Chem., 18, 1205-1212.
5. D'Amico, D. J.; Masonson, H. N.; Patel, M.; Adamis, A. P.; Cunningham, E. T. Jr.; Guyer, D. R.; Katz, B. (2006), Pegaptanib sodium for neovascular agerelated macular degeneration: two-year safety results of the two prospective, multicenter, controlled clinical trials. Ophthalmology, 113, 992-1001.
6. Drabovich, A.; Berezovski, M.; Krylov, S. N. (2005), Selection of smart aptamers by equilibrium capillary electrophoresis of equilibrium mixtures (ECEEM). J Am Chem Soc., 127, 11224-11225.
7. Ellington, A. D.; Szostak, J. W. (1990), In vitro selection of RNA molecules that bind specific ligands. Nature, 346(6287), 818-822.
8. Ferreira, C. S. M.; Missailidis, S. (2007), Aptamerbased therapeutics and their potential in radiopharmaceutical design. Brazilian Arch Biol Technol., 50, 63-76.
9. Ferreira, C. S. M.; Papamichael, K.; Guilbault, G.; Schwarzacher, T.; Gariepy, J.; Missailidis, S. (2008), DNA aptamers against MUC1: Design of aptamerantibody sandwich ELISA for early tumour diagnosis, Anal Bioanal Chem., 390, 1039-1050.
10. Hamaguchi, N.; Ellington, A.; Stanton, M. (2001), Aptamer Beacons for the Direct Detection of Proteins Anal Biochem., 294, 126-131.
11. Hamula, C. L. A.; Guthrie, J. W.; Zhang, H.; Li, X. F.; Le, X. C. (2006), Selection and analytical applications of aptamers. Trac-Trends Anal Chem., 25, 681-691.
12. Hesselberth, J.; Robertson, M. P.; Jhaveri, S.; Ellington, A. (2000), In vitro selection of nucleic acids for diagnostic applications Rev Mol Biotechnol., 74, 15-25.
13. Hicke, B. J.; Stephens, A. W.; Gould, T. (2006), Tumour targeting by an aptamer. J Nucl Med., 47, 668-678.
14. Jayasena, S. D. (1999), Aptamers: An emerging class of molecules that rival antibodies in diagnostics Clin Chem., 45, 1628-1650.
15. Jhaveri, S.; Rajendran, M.; Ellington, A. D. (2000), In vitro selection of signaling aptamers Nature Biotechnol., 18, 1293-1297.
16. Khan, H.; Missailidis, S. (2008), "Aptamers in oncology: A diagnostic perspective", Gene Ther Mol Biol., 12, 111-128.
17. Makwana, V.; Simmons, S.; Missailidis, S. "Aptamers as Anticancer Agents". In-Anticancer Therapeutics, Missailidis S (editor). Wiley and Sons Ltd, United Kingdom.
18. Missailidis, S., "Future Trends in Cancer Therapeutics". In-Anticancer Therapeutics, Missailidis S (editor). Wiley and Sons Ltd, UK.
19. Missailidis, S.; Perkins A. (2007), "Aptamers as Novel Radiopharmaceuticals: Their applications and Future Prospects in diagnosis and therapy", Cancer Biother Radiopharmaceuticals, 22, 453-468.
20. Morris, K. N.; Jensen, K. B.; Julin, C. M.; Weil, M.; (1998), High affinity ligands from in vitro selection: Complex targets. Proc Natl Acad Sci USA, 95, 2902- 2907.
21. Perkins, A.; Missailidis, S. (2007), "Radiolabelled aptamers for tumour imaging and therapy", Quarterly J Nucl Med Mol. Imag., 51, 292-296.
22. Potyrailo, R. A.; Conrad, R. C.; Ellington, A. D.; Hieftje, G. M. (1998), Adapting selected nucleic acid ligands (aptamers) to biosensors Anal Chem., 70, 3419-3425.
23. Tuerk, C.; Gold, L. (1990), Systematic evolution of ligands by exponential enrichment - Rna ligands to bacteriophage-T4 DNA-polymerase. Science, 249(4968), 505-510.